This Dallas Med Tech Company Reconstructs Faces of Ukrainian Soldiers
Founded in 2007, MedCAD uses advanced scans to 3D print bespoke titanium facial and cranial implants.
|
MedCAD’s surgical guide used to heal an orbital bone.
DALLAS TEXAS, October 22, 2024 (D Magazine) —
Dallas-based MedCAD is producing custom facial implants and cutting guides to assist Ukrainian soldiers injured in the ongoing war with Russia. Utilizing precise CT imaging and advanced 3D printing technology, the company creates bespoke titanium implants tailored to individual patients’ needs. This fall, a surgical team led by Dr. Jorge Corona will deliver these implants to Kyiv for reconstructive surgeries. Founded by Nancy Hairston, MedCAD focuses on personalized care rather than mass production, allowing for quick turnaround times. This partnership with LEAP Global Missions aims to provide high-quality facial restoration for soldiers affected by the conflict, with Hairston expressing deep pride in the transformative impact of their work.
Certain information set forth in this presentation contains “forward-looking information”, including “future-oriented financial information” and “financial outlook”, under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company’s business, projects, and joint ventures; (iv) execution of the Company’s vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company’s projects; (vi) completion of the Company’s projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company’s current customer, supplier and other material agreements; and (vii) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management’s beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment.
These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements.
Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.